中国新冠肺炎统计数据有什么问题?

Q3 Nursing

Epidemiology Biostatistics and Public Health Pub Date : 2023-07-18 DOI:10.54103/2282-0930/20637

I. Nesteruk

{"title":"中国新冠肺炎统计数据有什么问题?","authors":"I. Nesteruk","doi":"10.54103/2282-0930/20637","DOIUrl":null,"url":null,"abstract":"The media is reporting tens of millions of new daily Covid-19 cases in China in the final days of 2022. However, official statistics have recorded in mainland China only 1.9 million cases since the start of the pandemic and stopped providing data after December 21, 2022. Results of SIR simulations showed that daily numbers of new cases stated to decline in December 2022. The contradictions in statistics and estimations are discussed. Millions of new daily cases in China look very unlikely.","PeriodicalId":45811,"journal":{"name":"Epidemiology Biostatistics and Public Health","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"What is wrong with Chinese COVID-19 statistics?\",\"authors\":\"I. Nesteruk\",\"doi\":\"10.54103/2282-0930/20637\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The media is reporting tens of millions of new daily Covid-19 cases in China in the final days of 2022. However, official statistics have recorded in mainland China only 1.9 million cases since the start of the pandemic and stopped providing data after December 21, 2022. Results of SIR simulations showed that daily numbers of new cases stated to decline in December 2022. The contradictions in statistics and estimations are discussed. Millions of new daily cases in China look very unlikely.\",\"PeriodicalId\":45811,\"journal\":{\"name\":\"Epidemiology Biostatistics and Public Health\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Epidemiology Biostatistics and Public Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.54103/2282-0930/20637\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiology Biostatistics and Public Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54103/2282-0930/20637","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Nursing","Score":null,"Total":0}

引用次数: 2

摘要

据媒体报道，在2022年的最后几天，中国每天新增数千万例Covid-19病例。然而，自疫情开始以来，中国大陆的官方统计数据仅记录了190万例病例，并在2022年12月21日之后停止提供数据。SIR模拟结果显示，2022年12月，每日新增病例数将下降。讨论了统计和估计中的矛盾。中国每天新增数以百万计的病例看起来不太可能。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

What is wrong with Chinese COVID-19 statistics?

The media is reporting tens of millions of new daily Covid-19 cases in China in the final days of 2022. However, official statistics have recorded in mainland China only 1.9 million cases since the start of the pandemic and stopped providing data after December 21, 2022. Results of SIR simulations showed that daily numbers of new cases stated to decline in December 2022. The contradictions in statistics and estimations are discussed. Millions of new daily cases in China look very unlikely.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Epidemiology Biostatistics and Public Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

自引率

0.00%

发文量

期刊介绍： Epidemiology, Biostatistics, and Public Health (EBPH) is a multidisciplinary journal that has two broad aims: -To support the international public health community with publications on health service research, health care management, health policy, and health economics. -To strengthen the evidences on effective preventive interventions. -To advance public health methods, including biostatistics and epidemiology. EBPH welcomes submissions on all public health issues (including topics like eHealth, big data, personalized prevention, epidemiology and risk factors of chronic and infectious diseases); on basic and applied research in epidemiology; and in biostatistics methodology. Primary studies, systematic reviews, and meta-analyses are all welcome, as are research protocols for observational and experimental studies. EBPH aims to be a cross-discipline, international forum for scientific integration and evidence-based policymaking, combining the methodological aspects of epidemiology, biostatistics, and public health research with their practical applications.